Cellda AB is a Swedish company developing products with the aim to replace manual, time-consuming and subjective cancer diagnostics with safe, fast and objective automated diagnostics resulting in less suffering and better quality of life for patients and their relatives. The first solution developed, Cellda® Prostate, is an in-vitro software intended to assist pathologists in the review of scanned whole slide images from prostate needle biopsies prepared from immunohistochemistry (IHC) stained tissue. It is based on years of research and expertise and allows for assisting pathologists to make the diagnosis of prostate cancer faster, more cost-effective, objective and reproducible. With Cellda®Prostate and consequent products targeting other diseases, we aim to empower healthcare professionals with powerful tools that enhance the quality of patient care and contributes to the ongoing fight against cancer.
